Analysis/Buyouts
In Profile: Cerea Partenaire
Three-pronged food and agriculture investor is due to announce a first close for its second debt fund in March ahead of a final close on its €300m target
Deal in Focus: IK buys Studienkreis from Aurelius
IK had considered previous opportunities in the education space, with the firm's partner Petersson saying the sector offers good opportunities for PE
Deal in Focus: Ardian merges Spanish bakeries Berlys and Bellsolà
Ardian's investment in Berlys and Bellsolà forms part of a consolidation play in the European frozen food industry
Deal in Focus: Ambienta carves out Restiani from Total Erg
An in-depth look at a difficult carve-out in the energy production market segment
Deal in Focus: Ambienta bets on tighter market regulation with Safim
A look at the rationale behind the GP's 25th investment since the launch of its maiden fund in March 2008
Deal in Focus: Ufenau reaps 6x on NRW sale
Divestment of building refurbishment company follows a tenure of less than three years
Deal in Focus: Eurazeo buys Mondelēz confectionery arm for €157m
Following the deal, the company's international production will be relocated to France
Deal in Focus: Bain and Cinven to take Stada private
Acquisition of German pharmaceutical company would be the largest buyout ever recorded in the country
Deal in Focus: Ardian to take majority stake in Prosol
French hypermarket group reportedly valued in the region of €1bn, with existing investors remaining as minority backers following completion
Deal in Focus: Wise backs Tapì’s SBO
Italy-based bottle cap producer will adapt its expansion strategy to account for geopolitical developments in Central and North America
Deal in Focus: Cobalt makes 3.5x on TCS sale to Meeschaert
Vendor extended its holding period with LPs' blessing in order to fully implement its buy-and-build growth strategy
Deal in Focus: Hannover Finanz backs PWK’s MBO
An in-depth look at the GP’s acquisition of the German auto parts producer market
Deal in Focus: Advent, Bain buy German payment service Concardis
After Worldpay, Nets and ICBI, the Concardis deal marks the fourth acquisition in Europe for the private equity duo
Deal in Focus: Finint bets on green with BP-CVS merger
An in-depth look at the GP’s strategies to cope in a highly fragmented sector following the merger of BP and CVS
Deal in Focus: Ardian buys Equistone's Unither for €675m
Deal for French pharmaceuticals company will see the buisness enter its fourth consecutive period under PE ownership
Deal in Focus: IK buys Schock from HQ Equita
Despite entering into its third period of PE stewardship, the sink manufacturer's new owner is planning to double turnover during its tenure
Deal in Focus: Qualium and CDC IC acquire Vulcanic
Pass-the-parcel deal marks the fourth consecutive period for the French cooling systems group under private equity ownership
Deal in Focus: Riverside acquires panel-door maker Epco
GP is planning an international expansion strategy for the panel manufacturer, with a particular focus on central and eastern Europe
Deal in Focus: Siparex acquires Ligier from 21 Partners
Under the vendor's tenure, the microcar business embraced electrification and driverless technology, enabling expansion across Europe and farther afield
Deal in Focus: Naxicap acquires Texa from Apax
Following a successful buy-and-build strategy, Apax decided to divest the business rather than commit to a further three years of ownership
Deal in Focus: ECI and Livingbridge sell Reed & Mackay to Inflexion
Vendors' sale of the corporate travel company is their latest in a string of successful investments within the travel and tourism sector
Deal in Focus: Ardian buys Dedalus for market consolidation
An in-depth look at Ardian's most recent investment in the Italian healthcare technology sector
Deal in Focus: Colony Capital et al. exit French chain But
French homeware chain expanded through an aggressive marketing campaign, cost-cutting measures and by outsourcing production
Deal in Focus: Astorg sells Ethypharm after nine-year holding
Resisting regular suitors, the GP's nine-year tenure of the pharmaceutical company allowed it to fully implement a long-term acquisitive strategy
